“It’s almost impossible to avoid reactions and live in the real world,” said BJ Lanser, a pediatric allergy specialist at National Jewish Health in Denver [and associate professor of pediatrics at CU School of Medicine]. “That peace of mind and knowledge of the protection that is there is obviously of significant benefit to many.”
Roughly 35 years later, National Jewish researchers led by Donald Leung [professor of pediatrics at CU School of Medicine] studied the use of an anti-IgE drug to treat peanut allergies. The results of the study were so promising that Leung and his colleagues concluded the drug “should translate into protection against most unintended ingestions of peanuts.”
